Hydrochloric Acid

Hydrochloric Acid

SCHEMBL439854

CNC(=N)N.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27469418 1.00
SCHEMBL181641 0.96
SCHEMBL28868195 0.92
Guanidine SCHEMBL4428313 0.92
Ethane SCHEMBL27569889 0.92
SCHEMBL29183240 0.92
Bromide SCHEMBL11505134 0.92
Water SCHEMBL1971738 0.92
Methane SCHEMBL28838006 0.92
Iodide SCHEMBL9536874 0.92

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 641 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250313801-A1 SPECIFIC T CELL FOR PREVENTING OR TREATING CANCER, AND PREPARATION METHOD THEREOF SUZHOU ERSHENG BIOPHARMACEUTICAL CO., LTD. (CN) 2025-10-09 US claimed
CN-120004697-A Preparation method of OrgVO material and application of OrgVO material as secondary battery anode material 同济大学 2025-05-16 CN claimed
EP-4534652-A1 SPECIFIC T CELL FOR PREVENTING OR TREATING CANCER, AND PREPARATION METHOD THEREFOR Suzhou Ersheng Biopharmaceutical Co., Ltd. (CN) 2025-04-09 EP claimed
CN-119503795-A Modified activated carbon, silicon-carbon composite material, preparation method thereof, pole piece, application and electrochemical device 上海杉杉新材料有限公司 2025-02-25 CN claimed
CN-119331419-A Impact-resistant plastic packaging material and preparation method thereof 惠州市天富材料技术有限公司 2025-01-21 CN claimed
CN-119015834-A Carbon dioxide separation membrane and preparation method thereof 国家能源投资集团有限责任公司 2024-11-26 CN claimed
CN-118667104-A Degradable high polymer material and preparation method thereof 上海科技大学 2024-09-20 CN claimed
WO-2023227085-A1 SPECIFIC T CELL FOR PREVENTING OR TREATING CANCER, AND PREPARATION METHOD THEREFOR 苏州尔生生物医药有限公司 2023-11-30 WO claimed
CN-112952005-A Solar cell and preparation method thereof 南京邮电大学 2021-06-11 CN claimed
CN-110079020-A A kind of new energy vehicle battery pack upper cover anti-flaming polypropylene material and preparation method thereof 长沙而道新能源科技有限公司 2019-08-02 CN claimed
CN-102936225-A Method for preparing rosuvastatin calcium intermediate containing brooethyl, hydroxymethyl or formyl JIANGSU ALPHA PHARMACEUTICAL CO LTD 2013-02-20 CN claimed
CN-102311457-A Preparation method of rosuvastatin SUZHOU LAKESTAR PHARMATECH CO LTD 2012-01-11 CN claimed
CN-101190897-B Method for synthesizing 4-(4-fluorophenyl)-6-isopropyl-2-methylaminopyrimidine-5-formic acid ester TIANJIN TASLY GROUP CO LTD 2011-05-11 CN claimed
US-20100284954-A1 PROCESS FOR RELAXING KERATIN FIBRES L'OREAL (FR) 2010-11-11 US claimed
CN-100412065-C 4-(p-fluorophenyl)-6-isopropyl-2-methylaminopyrimidine-5-methyl formate synthesis method TIANJIN TASLY GROUP CO LTD (CN) 2008-08-20 CN claimed
US-20080146790-A1 Additive, Method, and Article For Dna Collection, Stabilization, and Purification PREANALYTIX GMBH (CH) 2008-06-19 US claimed
CN-101190897-A Method for synthesizing 4-(4-fluorophenyl)-6-isopropyl-2-methylaminopyrimidine-5-formic acid ester TIANJIN TASLY GROUP CO LTD (CN) 2008-06-04 CN claimed
US-20060127337-A1 Process for relaxing keratin fibres L'OREAL (FR) 2006-06-15 US claimed
WO-2006023471-A2 ADDITIVE, METHOD, AND ARTICLE FOR DNA COLLECTION, STABILIZATION, AND PURIFICATION PREANALYTIX GMBH (CH) 2006-03-02 WO claimed
CN-1733734-A 4-(p-fluorophenyl)-6-isopropyl-2-methylaminopyrimidine-5-methyl formate synthesis method TIANJIN TASLY GROUP CO LTD (CN) 2006-02-15 CN claimed